A 74-year-old man is admitted to the hospital with a 7-day history of fever, rigors, chest pain, and general weakness. He underwent coronary artery bypass surgery 10 years ago.
After 2 weeks of intravenous ceftriaxone 2 g/day, the patient undergoes excision of the mycotic pseudoaneurysm of the descending aorta, with placement of an aortic homograft. Biopsy of the excised aortic segment shows calcified fibroatheromatous plaques with no evidence of cystic medial degeneration or granulomas.
Mycotic aneurysm is a localized and irreversible dilatation of an artery due to destruction of the vessel wall by an infection. The dilatation is at least one and one-half times the normal diameter of the affected artery. It may be a true aneurysm or a pseudoaneurysm, involving all or some layers of the arterial wall. It is a rare but life-threatening condition.
A mycotic aneurysm can develop from septic embolization to the vasa vasorum, hematogenous seeding of an existing aneurysm, or extension from a contiguous site of infection.1,2 Mycotic infections of the aorta show a preference for male patients already infected with S enteritidis or S typhimurium. 3 Predisposing factors include rheumatic deformity of the valves, a bicuspid valve, impaired immunity,4 self-induced or iatrogenic arterial trauma,5,6 atherosclerotic deposits and calcification of the endovascular structure,7 and, in elderly patients, Salmonella septicemia.8,9 Computed tomography is the most useful imaging modality.10,11 Surgical interventions, in addition to parenteral antibiotic therapy for at least 6 weeks,11,12 are required to:
- Confirm the diagnosis
- Reconstruct the arterial vasculature
- Manage the complications of sepsis
- Start preventive measures (ie, cholecystectomy).2